Citius Pharmaceuticals, Inc. (CTXR) Reports Q1 Loss of $0.06
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q1 EPS of ($0.06).
For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Create E-mail Alert Related Categories
EarningsRelated Entities
Citi, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
